US2006122103A1PendingUtilityA1

Dalfopristine/quinupristine combinations with cefpirome

32
Assignee: FEGER CELINEPriority: Aug 3, 2000Filed: Jan 4, 2006Published: Jun 8, 2006
Est. expiryAug 3, 2020(expired)· nominal 20-yr term from priority
Inventors:Celine FegerPhillope MoreillonJacques Vouillamoz
A61P 31/04A61K 31/55A61K 38/04A61K 38/08
32
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical composition comprising synergistically effective amounts of cefpirome and dalfopristine/quinupristine combination. A method of treating a patient comprising the administration of synergistically effective amounts of cefpirome and a dalfopristine/quinupristine combination. Kits comprising synergistically effective amounts of cefpirome and a dalfopristine/quinupristine combination are also disclosed.

Claims

exact text as granted — not AI-modified
1 - 15 . (canceled)  
   
   
       16 . A kit comprising synergistically effective amounts of cefpirome and of a dalfopristine/quinupristine combination.  
   
   
       17 . A kit according to  claim 16 , wherein said kit is suitable for parenteral administration.  
   
   
       18 . A kit according to  claim 16 , wherein the cefpirome and the dalfopristine/quinupristine combination are each contained in a container independently chosen from an infusion bag, a vial, a bottle and a syringe.  
   
   
       19 . A kit according to  claim 18 , wherein the syringe is a double compartment syringe.

Join the waitlist — get patent alerts

Track US2006122103A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.